Home Tools
Log in
Cart

CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled

Catalog No. TMPK-01005
Synonyms: DCAL-2, HECL, CLL-1, CLECSF7, CD371, CLEC12A, PRO34150, MICL, CLECSF11, CD303, DLEC, DCAL2, CLL1

CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled is expressed in HEK293 mammalian cells with N-His tag. The predicted molecular weight is 24.6 kDa and the accession number is Q5QGZ9-2.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled
Pack Size Availability Price/USD Quantity
100 μg 5 days $ 1,400.00
500 μg 5 days $ 3,720.00
1 mg 5 days $ 6,210.00
Bulk Inquiry
Get quote
Contact us for more batch information
Biological Description
Technical Params
Product Properties
References and Literature
Description CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled is expressed in HEK293 mammalian cells with N-His tag. The predicted molecular weight is 24.6 kDa and the accession number is Q5QGZ9-2.
Species Human
Expression System HEK293 Cells
Tag N-His
Accession Number Q5QGZ9-2
Synonyms DCAL-2, HECL, CLL-1, CLECSF7, CD371, CLEC12A, PRO34150, MICL, CLECSF11, CD303, DLEC, DCAL2, CLL1
Construction His65-Ala265
Protein Purity > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
Molecular Weight 24.6 kDa (predicted). Due to glycosylation, the protein migrates to 35-55 kDa based on Tris-Bis PAGE result.
Endotoxin < 1 EU/μg by the LAL method.
Formulation Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
Stability & Storage

It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Shipping

In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.

Research Background CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.

References and Literature

Calculator

Reconstitution Calculator
Recombinant Proteins Dilute Calculator
Specific Activity Calculator
=
÷
X
=
X
(Unit/mg)
= 106 ÷
ng/mL

bottom

Tech Support

Please read the User Guide of Recombinant Proteins for more specific information.

Keywords

CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled CD-371 DCAL-2 HECL CLL-1 CLECSF7 CD371 CLEC12A PRO 34150 CD 371 PRO34150 MICL DCAL 2 CLECSF11 CLL 1 CD303 DLEC CD-303 CLECSF-7 CLECSF 11 CLECSF-11 DCAL2 CD 303 CLECSF 7 PRO-34150 CLL1 recombinant recombinant-proteins proteins protein

 

TargetMol